AlphaSense, a New York-based market intelligence, and search platform, raised $180 million in Series C financing. The round was led by Viking Global Investors and the Growth Equity business within Goldman Sachs Asset Management, joined by Morgan Stanley, Citi, Bank of America, Barclays, Wells Fargo Strategic Capital, Cowen Inc., and …

Activ Surgical™, a Boston, Massachusetts-based digital surgery pioneer, raised $45 million in a Series B financing round led by Cota Capital, a multi-stage investment firm focused on private and public modern enterprise technology companies. Seven new investors, including BAM Funds, Magnetar Capital, Mint Ventures, Castor Ventures, Dream One Vision, and …

SecZetta, a Fall River, Massachusetts-based leading provider of third-party identity risk solutions, raised a $20.5 Million Series B round. The round was led by SYN Ventures, along with new investor MassMutual Ventures. The round also included participation from existing investors ClearSky and Rally Ventures, which strengthened their investments in SecZetta. …

Botco.ai, an AI-powered conversational marketing platform, recently secured $3.6 million in additional seed funding from VamosVentures. Botco.ai will use the new capital to develop its chatbot analytics to help users drive greater engagement in digital channels. Botco.ai also plans to expand its integration capabilities with other CRM systems to simplify …

Amplified Intelligence, an Adelaide, Australia-based Global attention measurement platform, closed A$3 million (£1.6m) in a Seed round. The round is led by TEN13 – a market-leading investment syndicate co-founded by Aussie tech entrepreneur and Shark (‘Shark Tank’) Steve Baxter. The funds will be used to accelerate the company’s product roadmap …

Baresquare, a London, England-based analytics company, raised $2.5 million in a seed funding round led by European venture capital firm btov Partners. The round was joined by Marios Stavropoulos, former Co-Founder & CEO of Softomotive (now part of Microsoft Power Automate; acquired by Microsoft in 2020), and Kostas Tzoumas, former …

Envisagenics, a New York-based Artificial Intelligence-driven biotechnology company focused on the discovery and development of novel RNA splicing therapeutics, secured Series A financing to scale its drug discovery platform and biopharmaceutical partnerships. Red Cell Partners led the financing, which included investments from Microsoft's M12, Madrona Venture Group, Third Kind Venture …